Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06025253
Other study ID # RCSI-PINTA
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date December 1, 2026

Study information

Verified date August 2023
Source Royal College of Surgeons, Ireland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.


Description:

Many factors influence the risk wound complications. Notably, the presence of unreconstructed proximal occlusive arterial disease is a major influence on stump healing. Patient factors such as smoking, diabetes, obesity, malnutrition and chronic kidney disease are non-modifiable, particularly in the short-term setting. However, surgical factors may be altered in an effort to reduce the risk of wound complications. One option amenable to alteration is what dressing is applied to the closed incision upon procedure completion. The type of dressing may influence factors such as bacterial access to the wound, the development of collections of blood or fluid in the wound or fluid oozing from the wound. Collectively, these wound factors increase the risk of wound infection. Therefore, dressings which reduce these factors have the potential to reduce wound breakdown, thereby reducing the burden for patients and healthcare systems. Negative pressure wound therapy (NPWT) removes excess fluid from wounds as well as limiting bacterial access. Negative pressure dressings consistent of an open cell solid foam, placed on top of the incision and then covered with a semipermeable membrane. A sealed tube connects the foam to a pump to create a partial vacuum over the wound. This negative pressure leads to a sealed environment which prevents bacterial migration into the wound while removing blood and serous exudate. Single-use NPWT systems (such as Smith & Nephew's PICOTM and Acelity's PrevenaTM) are now widely available. The systems can be applied and left in place for up to seven days. Prophylactic NPWT in the setting of closed surgical incisions has been widely evaluated. The most recent Cochrane review analysed data from 62 randomised controlled trials (RCTs) and 6 economic studies. Data were reported from 13,340 participants, undergoing a wide range of procedures (gastrointestinal, gynaecological, vascular, orthopaedic and cardiothoracic). The review was concluded with moderate certainty that prophylactic NPWT reduces SSI but not wound dehiscence. There was a possibility that prophylactic NPWT reduces mortality although the confidence intervals include the possibility of harm. Cost effectiveness studies produced differing results in differing settings with no high-grade evidence of cost efficacy. However, studies specifically investigating the impact of NPWT on closed incision major LEAs are scarce. Early results from a pilot study of prospective, multi-centre, two-arm, randomized controlled trial comparing NPWT to standard dressings after above knee amputations (AKA) and below-knee amputations (BKA) reported promising results. In this initial review of 43 patients, NPWT reduced the wound complication rates at 30 days, with complications noted in 5 of 21 controls (23.8%) and 1 of 22 (4.5%) in the treatment group (p=0.068). Despite this, the absence of robust cost effectiveness data to support the routine use of NPWT is of concern. NPWT is considerably more expensive than traditional dressings (approximately £120-145 versus £4 for a standard dressing). In addition, the Cochrane reviewers noted that pain and health-related quality of life were not reported by most of their included RCTs. Most studies randomised patients at high-risk for wound complications but did not always define high-risk clearly. Finally, the definition of surgical site infection varied amongst included studies. In particular, it remains unclear whether NPWT reduces all wound infections, superficial infections alone or deep infections. Negative-pressure wound dressings rely on a robust seal around the wound to function. This can be difficult to achieve on the relatively irregular shape of a major limb amputation wound. Seal failures often result in dressings changes, substantially increasing associated costs. Prospective evaluation of wound complications in a trial setting utilising standardised criteria will generate a robust baseline rate upon which to generate a sample size calculation for a full trial. We propose to conduct a multicentre randomised controlled trial comparing prophylactic single-use negative pressure wound therapy with standard dressings in patients with in patients with a closed incision following major lower extremity amputation in terms of SSI incidence, wound healing complications and scar appearance, patient quality of life and financial impact on the patient and healthcare system.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 728
Est. completion date December 1, 2026
Est. primary completion date December 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients aged 18 years or older; - Patients undergoing major lower extremity amputation, including below-knee amputation, through-knee amputation and above-knee amputation, for any indication; - Patients with primary closure of the surgical incision using either interrupted or continuous sutures Exclusion Criteria: - Patients <18 years; - Women who are pregnant and/or breast-feeding; - Patients with amputations performed without primary skin closure, including guillotine amputations, amputations deliberately left open for drainage purposes and amputations with soft tissues defects at the stump; - Patients with amputations where skin glue is the only means of skin closure - Patients with a clinically absent femoral pulse

Study Design


Intervention

Device:
Negative Pressure Wound Therapy
Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation
Standard Wound Dressing
Application of standard wound dressing post major lower extremity amputation

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Royal College of Surgeons, Ireland

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with a wound complication of the amputation stump, including wound infection, dehiscence, seroma, haematoma and stump necrosis. The Centre for Disease Control and Prevention definitions of surgical site infection will be used. 1 month post surgery
Secondary Number of days to discharge The length of time the patient is in hospital from date of surgery to date of discharge 6 months
Secondary Number of patients who require Re-operations within 1 month of surgery Any re-operations undertaken 1 Month
See also
  Status Clinical Trial Phase
Recruiting NCT02905955 - Vacuumtherapy After Venous Hybrid Procedures Phase 4
Not yet recruiting NCT02868372 - Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine N/A
Enrolling by invitation NCT02559453 - Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds N/A
Completed NCT02744144 - Wound Bacterial Microbiota and Their Antibiotic Resistance N/A
Active, not recruiting NCT01939145 - Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation Phase 4
Completed NCT00998907 - PDS*Plus and Wound Infections After Laparotomy N/A
Completed NCT01141335 - Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair Phase 4
Completed NCT00576745 - A Comparison Of The 3M TM S Surgical Skin Closure System To The Standard Vicryl Suture Closure of Sternotomy Incisions During Cardiac Surgery Phase 1
Terminated NCT00654641 - Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy N/A
Completed NCT00402727 - Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Phase 3
Recruiting NCT00150852 - Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus. Phase 2
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT04596124 - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze N/A
Active, not recruiting NCT04584957 - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.) N/A
Recruiting NCT03960970 - Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Phase 2
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Completed NCT02018094 - The Amputation Surgical Site Infection Trial (ASSIT) Phase 4
Terminated NCT03269968 - Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery N/A
Enrolling by invitation NCT02945761 - High Concentration of Sugar Solution Irrigation Promotes the Healing of Infected Wound N/A
Not yet recruiting NCT02882360 - Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum Phase 4